Answers are grounded in this paper and cite their sources.
TP42/40 demonstrated value in the identification of individuals suffering a-MCI, in the prediction of progression to dementia, and in the detection of underlying AD pathology revealed by FDG-PET, Amyloid-PET and CSF biomarkers, being, thus, consistently associated with all the well-established indicators of AD.
No takes yet. Share an insight, caveat, or question.
Pérez‐Grijalba et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: